Past and Present grant events

Rheumatoid Arthritis Educational Program

NWVU conducted disease education that reached individuals living with Rheumatoid Arthritis (RA), those at high-risk for the condition, and their caregivers. The intervention was successful as attendees were actively engaged during the question-and-answer sessions with improved knowledge on available treatment options and where to access the resources for RA management Pfizer supported the intervention between October 2023 and March 2024.

Colorectal Cancer Education Program

This Pfizer and Takeda supported intervention addressed knowledge gap of colorectal cancer among veterans and the general population, particularly among individuals with the disease and those at high risk for the condition in medically underserved communities in Cook County. The intervention was timely as more studies showed that “Early-onset colorectal cancer is increasing in the USA. New insights were gained on the prevention and treatment options for the condition. Here was high demand and calls for more disease education considering the fact that most of the target population have extensive histories of family members with cancer.

Phenylketonuria Awareness and Educational Program

NWVU conducted a successful outreach event on Phenylketonuria Awareness and Educational Program that was supported by BioMarin between October 15, 2023, and April 15, 2024. The 6 months intervention was successful as new insights were gained on the rare disease among the target audience. Due to partial funding, we were only about to reach about 40% of the target audience despite the great demand for this disease education. NWVU will continue to solicit for more funding to expand the intervention to other members of the County.

Colorectal Cancer Education Program II

This is an ongoing intervention in response for more disease education programs on colorectal cancer. Takeda graciously supported the second phase of the intervention generously, and more individuals living with the cancer and those at high-risk are gaining new insights regarding the prevention, treatment options, and care management of the disease.